Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP382926.RA-FhH-R51jhnhfynB5gFIjwYlV9uYnBsRrHUPNGG36rk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP382926.RA-FhH-R51jhnhfynB5gFIjwYlV9uYnBsRrHUPNGG36rk130_assertion type Assertion NP382926.RA-FhH-R51jhnhfynB5gFIjwYlV9uYnBsRrHUPNGG36rk130_head.
- NP382926.RA-FhH-R51jhnhfynB5gFIjwYlV9uYnBsRrHUPNGG36rk130_assertion description "[We found that these women were at significantly higher breast cancer risk if they carried alleles with at least 28 or 29 polyglutamine repeats at AIB1, compared with women who carried alleles with fewer polyglutamine repeats [odds ratio (OR), 1.59; 95% confidence interval (CI), 1.03-2.47 and OR, 2.85; 95% CI, 1.64-4.96, respectively].]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP382926.RA-FhH-R51jhnhfynB5gFIjwYlV9uYnBsRrHUPNGG36rk130_provenance.
- NP382926.RA-FhH-R51jhnhfynB5gFIjwYlV9uYnBsRrHUPNGG36rk130_assertion evidence source_evidence_literature NP382926.RA-FhH-R51jhnhfynB5gFIjwYlV9uYnBsRrHUPNGG36rk130_provenance.
- NP382926.RA-FhH-R51jhnhfynB5gFIjwYlV9uYnBsRrHUPNGG36rk130_assertion SIO_000772 11454686 NP382926.RA-FhH-R51jhnhfynB5gFIjwYlV9uYnBsRrHUPNGG36rk130_provenance.
- NP382926.RA-FhH-R51jhnhfynB5gFIjwYlV9uYnBsRrHUPNGG36rk130_assertion wasDerivedFrom befree-20140225 NP382926.RA-FhH-R51jhnhfynB5gFIjwYlV9uYnBsRrHUPNGG36rk130_provenance.
- NP382926.RA-FhH-R51jhnhfynB5gFIjwYlV9uYnBsRrHUPNGG36rk130_assertion wasGeneratedBy ECO_0000203 NP382926.RA-FhH-R51jhnhfynB5gFIjwYlV9uYnBsRrHUPNGG36rk130_provenance.